RESCUE OF HIPPO CO-ACTIVATOR YAP1 TRIGGERS DNA DAMAGE-INDUCED APOPTOSIS IN HEMATOLOGICAL CANCERS

[1]  Y. Shaul,et al.  The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl , 2013, Cell Death and Differentiation.

[2]  S. Dupont,et al.  Molecular Pathways Molecular Pathways : YAP and TAZ Take Center Stage in Organ Growth and Tumorigenesis , 2013 .

[3]  David M. Thomas,et al.  The Hippo pathway and human cancer , 2013, Nature Reviews Cancer.

[4]  Timothy C Greiner,et al.  Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies. , 2012, Blood.

[5]  F. Camargo,et al.  Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance , 2011, Proceedings of the National Academy of Sciences.

[6]  A. Dispenzieri,et al.  Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX , 2011, Leukemia.

[7]  J. Settleman,et al.  A kinase shRNA screen links LATS2 and the pRB tumor suppressor. , 2011, Genes & development.

[8]  Trevor J Pugh,et al.  Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.

[9]  D. Pan,et al.  The hippo signaling pathway in development and cancer. , 2010, Developmental cell.

[10]  G. Morgan,et al.  A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. , 2010, Blood.

[11]  Jeannie T. Lee,et al.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. , 2009, Cancer cell.

[12]  L. Galluzzi,et al.  Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome , 2009, Oncogene.

[13]  M. Sudol,et al.  YAP: At the crossroad between transformation and tumor suppression , 2009, Cell cycle.

[14]  P. Pandolfi,et al.  PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. , 2008, Molecular cell.

[15]  Jiri Bartek,et al.  An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.

[16]  Y. Shaul,et al.  Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. , 2008, Molecular cell.

[17]  L. Bruhn,et al.  Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. , 2007, Cancer cell.

[18]  L. Staudt,et al.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. , 2007, Cancer cell.

[19]  Y. Shaul,et al.  The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73 , 2007, Cell Death and Differentiation.

[20]  L. Chin,et al.  High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. , 2006, Cancer cell.

[21]  W. Kaelin.  The Concept of Synthetic Lethality in the Context of Anticancer Therapy , 2005, Nature Reviews Cancer.

[22]  G. Blandino,et al.  Erratum: The transcriptional coactivator yes-associated protein drives p73 gene-target specificity in response to DNA damage (Molecular Cell (2005) 18 (441-459)) , 2005 .

[23]  G. Blandino,et al.  The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. , 2005, Molecular cell.

[24]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[25]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[26]  Tohru Natsume,et al.  JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage , 2005, Nature Cell Biology.

[27]  N. Curtin,et al.  Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM , 2004, Cancer Research.

[28]  David W. Anderson,et al.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Castagnoli,et al.  Physical interaction with Yes-associated protein enhances p73 transcriptional activity. , 2001, The Journal of biological chemistry.

[30]  D. Baltimore,et al.  Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation , 1997, Nature.

[31]  Y. Shiloh,et al.  Interaction between ATM protein and c-Abl in response to DNA damage , 1997, Nature.

[32]  N. McCarthy,et al.  A sense-abl response? , 1997, Nature.

[33]  R. Weichselbaum,et al.  Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Chernoff,et al.  The Ste20-like Protein Kinase, Mst1, Dimerizes and Contains an Inhibitory Domain* , 1996, The Journal of Biological Chemistry.

[35]  R. Weichselbaum,et al.  Role for c-Abl tyrosine kinase in growth arrest response to DNA damage , 1996, Nature.

[36]  R. Weichselbaum,et al.  Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents , 1995, Nature.

[37]  M. Sudol,et al.  Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. , 1994, Oncogene.

[38]  Hollis G. Potter,et al.  Author Manuscript , 2013 .

[39]  J. Downward,et al.  Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. , 2003, Molecular cell.

[40]  N. McCarthy,et al.  DNA repair. A sense-abl response? , 1997, Nature.